Benazin-12.50 Tablet

About Benazin-12.50 12.5 mg Tablet

Benazin-12.50 is a tablet containing tetrabenazine 12.5 mg, used to treat the involuntary jerky movements called chorea that can occur in Huntington's disease. It works by reducing certain chemical messengers in the brain.

There are 4 brands of Tetrabenazine listed in Bangladesh. The lowest listed price is Ticstop 12.5 Tablet at ৳ 20 per unit.

What is Benazin-12.50 12.5 mg Tablet?

Benazin-12.50 is a tablet made by Renata PLC. containing tetrabenazine 12.5 mg. It belongs to a group of medicines called atypical neuroleptic drugs. It is prescribed for chorea linked to Huntington's disease, where unwanted jerky movements affect daily life. The medicine lowers the levels of certain chemical messengers in the brain that are involved in movement control. It is a prescription medicine, and the doctor decides the dose and how long it is taken. You should not start, change or stop it without medical advice.

Uses of Benazin-12.50

Benazin-12.50 is used to treat chorea associated with Huntington's disease. Chorea means irregular, jerky movements that a person cannot control. This medicine is given to help reduce those movements. It is not a general treatment for all movement disorders and should only be used when a doctor has prescribed it for this purpose. Ask the doctor if you are unsure why it has been prescribed for you.

How to use Benazin-12.50

Take Benazin-12.50 exactly as the doctor tells you. The doctor sets the dose and course for each person and may adjust it gradually over time. The tablet can be taken with or without food. Swallow it as directed, and do not change the amount or stop suddenly on your own. If you miss a dose, ask the doctor or pharmacist what to do. Keep it out of reach of children.

Side effects of Benazin-12.50

Side effects to watch for include restlessness, agitation, unusual movements, parkinsonism-like stiffness or tremor, difficulty swallowing, and drowsiness. Depression and suicidal thoughts are serious concerns with this medicine. Tell the doctor promptly if you notice low mood, thoughts of self-harm, or any movement or swallowing problems. Seek medical help right away if these occur or worsen. The doctor will decide how to manage any side effect.

Safety and precautions

Benazin-12.50 is not for people who are actively suicidal or have untreated or poorly treated depression, liver problems, or who are taking monoamine oxidase inhibitors. It may worsen parkinsonism, so tell the doctor about any such condition. Avoid driving or skilled tasks if you feel drowsy. It should be used in pregnancy only if the doctor judges the benefit outweighs the risk, and breastfeeding decisions should be discussed with the doctor. Always ask the doctor or pharmacist first about any concerns.

Frequently asked questions

What is Benazin-12.50 used for and what kind of medicine is it?

It is a tablet containing tetrabenazine 12.5 mg, an atypical neuroleptic drug. It is used to treat chorea, the involuntary jerky movements that can occur in Huntington's disease. It is a prescription medicine, so the doctor decides if it is suitable for you.

Who should avoid Benazin-12.50 or ask the doctor first?

People who are actively suicidal, have untreated or poorly treated depression, have liver problems, or take monoamine oxidase inhibitors should not use it. Tell the doctor if you have parkinsonism or are pregnant or breastfeeding. Ask the doctor or pharmacist before starting it.

What side effects should I watch for and when should I call the doctor?

Watch for restlessness, agitation, unusual movements, stiffness, trouble swallowing, and drowsiness. Depression and suicidal thoughts are serious. Contact the doctor promptly if low mood, self-harm thoughts, or movement or swallowing problems appear, and seek urgent help if they worsen.

Can I drive or do skilled tasks while taking Benazin-12.50?

This medicine may cause drowsiness or sedation, so be careful when driving or doing tasks that need alertness. Avoid these activities if you feel sleepy or unwell. Ask the doctor or pharmacist for advice about your own situation before driving.

Indications

Tetrabenazine is indicated for the treatment of chorea associated with Huntington's disease.

Pharmacology

Prolongation of the QTc interval has been observed at doses of 50 mg. In rats, it has been observed that tetrabenazine or its metabolites bind to melanin-containing tissues such as the eyes and skin. After a single oral dose of radiolabeled tetrabenazine, radioactivity was still detected in eye and fur at 21 days post dosing.

Tetrabenazine is a reversible human vesicular monoamine transporter type 2 inhibitor (Ki = 100 nM). It acts within the basal ganglia and promotes depletion of monoamine neurotransmitters serotonin, norepinephrine, and dopamine from stores. It also decreases uptake into synaptic vesicles. Dopamine is required for fine motor movement, so the inhibition of its transmission is efficacious for hyperkinetic movement. Tetrabenazine exhibits weak in vitro binding affinity at the dopamine D2 receptor (Ki = 2100 nM).

Dosage & Administration

General Dosing Considerations:

The chronic daily dose of Tetrabenazine used to treat chorea associated with Huntington's disease (HD) is determined individually for each patient. When first prescribed, Tetrabenazine therapy should be titrated slowly over several weeks to identify a dose of XENAXINE that reduces chorea and is tolerated. Tetrabenazine can be administered without regard to food.

Individualization Of Dose:

Dosing Recommendations Up to 50 mg per day: The starting dose should be 12.5 mg per day given once in the morning. After one week, the dose should be increased to 25 mg per day given as 12.5 mg twice a day. Tetrabenazine should be titrated up slowly at weekly intervals by 12.5 mg daily, to allow the identification of a tolerated dose that reduces chorea. If a dose of 37.5 to 50 mg per day is needed, it should be given in a three times a day regimen. The maximum recommended single dose is 25 mg. If adverse reactions such as akathisia, restlessness, parkinsonism, depression, insomnia, anxiety or sedation occur, titration should be stopped and the dose should be reduced. If the adverse reaction does not resolve, consideration should be given to withdrawing Tetrabenazine treatment or initiating other specific treatment (e.g., antidepressants).

Dosing Recommendations Above 50 mg per day: Patients who require doses of Tetrabenazine greater than 50 mg per day should be first tested and genotyped to determine if they are poor metabolizers (PMs) or extensive metabolizers (EMs) by their ability to express the drug metabolizing enzyme, CYP2D6. The dose of Tetrabenazine should then be individualized accordingly to their status as PMs or EMs

Extensive and Intermediate CYP2D6 Metabolizers:

Genotyped patients who are identified as extensive (EMs) or intermediate metabolizers (IMs) of CYP2D6, who need doses of Tetrabenazine above 50 mg per day, should be titrated up slowly at weekly intervals by 12.5 mg daily, to allow the identification of a tolerated dose that reduces chorea. Doses above 50 mg per day should be given in a three times a day regimen. The maximum recommended daily dose is 100 mg and the maximum recommended single dose is 37.5 mg. If adverse reactions such as akathisia, parkinsonism, depression, insomnia, anxiety or sedation occur, titration should be stopped and the dose should be reduced. If the adverse reaction does not resolve, consideration should be given to withdrawing Tetrabenazine treatment or initiating other specific treatment (e.g., antidepressants)

Interaction

Tetrabenazine should not be given with or within 14 days of discontinuation of MAOI therapy. Blocks action of reserpine. Decreases effects of levodopa and worsen parkinsonism. Increased risk of extrapyramidal side effects when given with amantadine, metoclopramide, antipsychotics.

Contraindications

Tetrabenazine is contraindicated in patients:
  • Who are actively suicidal, or in patients with untreated or inadequately treated depression 
  • With hepatic impairment 
  • Taking monoamine oxidase inhibitors (MAOIs). XENAZINE should not be used in combination with an MAOI, or within a minimum of 14 days of discontinuing therapy with an MAOI 

Side Effects

The following serious adverse reactions are Depression, Suicidality Akathisia, restlessness, and agitation, Parkinsonism, Dysphagia, Sedation and somnolence

Pregnancy & Lactation

Pregnancy Category C. There are no adequate and well-controlled studies in pregnant women. Tetrabenazine should be used during pregnancy only if the potential benefit justifies the potential risk to the fetus.

Nursing Mothers: It is not known whether Tetrabenazine or its metabolites are excreted in human milk. Since many drugs are excreted into human milk and because of the potential for serious adverse reactions in nursing infants from Tetrabenazine, a decision should be made whether to discontinue nursing or to discontinue Tetrabenazine, taking into account the importance of the drug to the mother.

Precautions & Warnings

May exacerbate symptoms of parkinsonism. Caution to be exercised when driving or performing skilled tasks. Pregnancy.

Overdose Effects

Three episodes of overdose occurred in the open-label trials performed in support of registration. Eight cases of overdose with Tetrabenazine have been reported in the literature. The dose of Tetrabenazine in these patients ranged from 100 mg to 1g. Adverse reactions associated with Tetrabenazine overdose include acute dystonia, oculogyric crisis, nausea and vomiting, sweating, sedation, hypotension, confusion, diarrhea, hallucinations, rubor, and tremor.

Treatment should consist of those general measures employed in the management of overdosage with any CNS-active drug. General supportive and symptomatic measures are recommended. Cardiac rhythm and vital signs should be monitored. In managing overdosage, the possibility of multiple drug involvement should always be considered. The physician should consider contacting a poison control center on the treatment of any overdose.

Alternative brands of Tetrabenazine

Other brands with the same generic name, cheapest first.

Medicine information is for reference only and is not medical advice. Always follow your doctor's prescription and check with a pharmacist.